DCSIMG

Decision awaited on cystic fibrosis treatment available in England

The Scottish Medicines Consortium (SMC) is to reveal tomorrow whether they have decided to issue the life-transforming medicine on the NHS

The Scottish Medicines Consortium (SMC) is to reveal tomorrow whether they have decided to issue the life-transforming medicine on the NHS

THE wait has been “cruel”, Marion Ferguson says. Her son, 15-year-old Thomas, suffers from the “Celtic” form of cystic fibrosis, or type G551D. Since early last year, when Kalydeco started being used in the United States with spectacular results, families across the world whose lives had been affected by the disease had known there was hope.

 
 
 

Back to the top of the page